GlassScriptPhysician profile
Quyen Dang
NPI 1033347604
$13,363.80
in general payments reported to CMS, 2019-2025
42 companies · $8,471 in 2025
The $8,471 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $192 · 2020: $43.27 · 2021: $320 · 2022: $494 · 2023: $710 · 2024: $3,132 · 2025: $8,471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $1,714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,600.00 |
| Food and Beverage | $1,713.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $10,600.00 | 2024-2025 | Bovine Collagen |
| Abbvie INC. | $310.06 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Pfizer INC. | $256.43 | 2021-2024 | |
| Organon LLC | $199.13 | 2021-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $164.17 | 2022-2025 | Aptima, Thinprep 2000 Processor, Novasure |
| Astellas Pharma US INC | $163.32 | 2023-2025 | Veozah |
| Exeltis, USA INC. | $162.41 | 2020-2025 | Slynd |
| Innovation Technologies INC | $156.02 | 2022-2024 | Irrisept |
| Myriad Women'S Health, INC. | $143.43 | 2023 | Myrisk |
| Gynesonics, INC. | $133.16 | 2022 | |
| Mayne Pharma Commercial LLC | $91.70 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $67.90 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $58.01 | 2023-2025 | Myfembree |
| Millicent US INC | $53.76 | 2023-2025 | Intrarosa, Femlyv, Femring |
| Sage Therapeutics, LLC | $53.66 | 2024-2025 | Zurzuvae |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Quyen Dang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.